India Contract Manufacturing Organization (CMO) Market 2022 Size, Status and Growth Outlook - AMRI India Pvt. Ltd., Dr. Reddy’s Laboratories, Cadila Healthcare Limited, MSN Laboratories Pvt Ltd

The India Contract Manufacturing Organization (CMO) Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The Indian CMO market was valued at USD 10.51 billion in 2020, and it is expected to reach USD 27.80 billion by 2026, at a CAGR of 17.6%, during the period of 2021 - 2026.

Get Free Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/02082592899/india-contract-manufacturing-organization-cmo-market-growth-trends-covid-19-impact-and-forecasts-2021-2026/inquiry?Mode=AD                                                       

Top Leading Companies of India Contract Manufacturing Organization (CMO) Market are AMRI India Pvt. Ltd., Dr. Reddy’s Laboratories, Cadila Healthcare Limited, MSN Laboratories Pvt Ltd., Mylan Laboratories Ltd., Medipaams India Pvt Ltd., Cipla Ltd., Eisai Pharmaceuticals India Pvt Ltd., Delwis Healthcare Pvt Ltd., Maxheal Pharmaceuticals India Ltd., Rhydburg Pharmaceuticals Ltd. and others.

Industry News and Updates

Sep 2019 - Eisai Pharmaceuticals India Pvt Ltd and Mylan Pharmaceuticals Pvt Ltd entered into a marketing license agreement, to commercialize TECERIS, the innovator's second brand of the anticancer agent, Eribulin mesylate (Eribulin), in India. TECERIS is likely to be manufactured and supplied by Eisai India and marketed by Mylan. This partnership was an important strategy for expanding the access of Eribulin, for the treatment of metastatic breast cancer (MBC) patients in India.

- Apr 2019 - The Cipla Ltd., launched Niveoli, India's first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targeting drug delivery to small airways. Niveoli is a proprietary Cipla inhaler, and the latest offering from Cipla in respiratory inhalation therapy that addresses an unmet need associated with obstructive airway diseases (OAD), such as asthma and chronic obstructive pulmonary disorder (COPD).

Key Market Trends

Drugs and Pharma Exports in United States Account for Significant Market Growth

- United States relies on India for importing services and also for establishing its plants in the country. The United States and North America contribute to over 30% of the country's outbound shipments.

- The FDA in 2019 estimated that about 80% of the medicine in the United States is imported every year. As of 2019, India has the highest number of FDA approved drug manufacturing facilities. India has over 600, US FDA-approved plants which is highest outside the United States.

- Furthermore, the US market faced a considerable price erosion in 2018, due to which the profit margins slimmed for the companies in the United States. The IDMA estimates that there is a 50% price reduction in the overall research, API, and manufacturing process, when it is outscored to emerging countries, like India and China. This will further boost the demand for CMO services in India and increase the export revenue in the future.

Regional Outlook of India Contract Manufacturing Organization (CMO) Market report includes the following geographic areas such as: North America, Europe, China, Japan, Southeast Asia, India and ROW.

Browse Full Report at:

https://www.marketinsightsreports.com/reports/02082592899/india-contract-manufacturing-organization-cmo-market-growth-trends-covid-19-impact-and-forecasts-2021-2026?Mode=AD                                                                

What Are The Market Factors That Are Explained In The Report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Analytical Tools: The India Contract Manufacturing Organization (CMO) Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team (sales@marketinsightsreports.com).

Contact US:
Irfan Tamboli (Head of Sales) : Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.